Multidrug resistance gene (MDR 1) expression in neuro-axial tumours of children and young adults

References

• International Incidence of Childhood Cancer, D M Parkin, C A Stiller, G J Draper, C A Bieber, B Terracini, J L Young. IARC Scientific Publication, Lyon 1988, No. 87
   Google Scholar
• Stiller C A, Bunch K J. Trends in survival for childhood cancer in Britain diagnosed 1971–1985. Br J Cancer 1990; 45: 543–51
   Google Scholar
• Silverman C L, Palkes H, Talent B, Kovnar E, Clouse J W, Thomas P RM. Late effects of radiotherapy on patients with cerebellar medulloblas-toma. Cancer 1984; 54: 825–9
   PubMed Web of Science ®Google Scholar
• Baram T Z, van Eys J, Dowell R, Cangir A, Pack B, Bruner J M. Survival and neurologic outcome of infants with medulloblastoma treated with surgery and MOPP chemotherapy. Cancer 1987; 60: 173–7
   PubMed Web of Science ®Google Scholar
• Haddad S F, Menezes A H, Bell W E, Godersky J C, Ann A K, Bale J F. Brain tumors occurring before 1 year of age: a retrospective review of 22 cases in an 11 year period (1977–1987). Neurosurgery 1991; 29: 8–13
   PubMed Web of Science ®Google Scholar
• Walker R W, Allen J C. Cisplatin in the treatment of recurrent childhood primary brain tumours. J Clin Oncol 1988; 6: 62–6
   PubMed Web of Science ®Google Scholar
• Zelter P M, Epport K, Nelson M D, Huff K, Gaynon P. Prolonged response to carboplatin in an infant with brain stem glioma. Cancer 1991; 67: 43–7
   PubMed Web of Science ®Google Scholar
• Tait D M, Thornton-Jones H, Bloom H J. Adjuvant chemotherapy for medulloblastoma, the first multicentre controlled trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 1990; 26: 464–9
   PubMed Web of Science ®Google Scholar
• Gottesman M M. How cancer cells evade chemotherapy: 16th Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 1993; 53: 747–54
   PubMed Web of Science ®Google Scholar
• Fojo A, Lebo R, Shimizu N, et al. Localization of multidrug resistance-associated DNA sequences to human chromosome 7. Somat Cell Mol Genet 1986; 12: 415–20
   PubMedGoogle Scholar
• Chan H S, Thorner P S, Haddad G, Ling V. Im-munohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 1990; 84: 689–704
   Google Scholar
• Chan H S, Thorner P S, Haddad G, Gallie B L. Multidrug-resistant phenotype in retinoblastoma correlates with P-glycoprotein expression. Ophthalmology 1991; 98: 1425–31
   PubMed Web of Science ®Google Scholar
• Chan H S, Haddad G, Thorner P S, et al. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med 1991; 325: 1608–14
   PubMed Web of Science ®Google Scholar
• Mizuno Y, Hara T, Nagat M, Tawa A, Tsuruo T, Ueda K. Detection of multidrug-resistant protein, P-glycoprotein in childhood leukaemia and lymphoma. Eur J Pediat 1991; 150: 416–8
   PubMed Web of Science ®Google Scholar
• Marie J P, Zittoun R, Sikie B I. Multidrug resistance (mdrl) gene expression in adult acute leukaemias: correlations with treatment outcome and in vitro drug sensitivity. Blood 1991; 78: 586–92
   PubMed Web of Science ®Google Scholar
• Musto P, Melillo L, Lombardi G, Matera R, Giorgio G, Carotenuto M. High risk of early relapse for leukaemic patients with presence of multidrug resistance associated P-glycoprotein positive cells in complete remission. Br J Haematol 1991; 77: 50–3
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo C, O'Brien J P, Casals D, Bertino J R, Melamed M R. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Nat Acad Sci USA 1989; 86: 695–8
   PubMed Web of Science ®Google Scholar
• Nabors M W, Griffin C A, Zehnbauer B A, et al. Multidrug resistance gene (MDR1) expression in human brain tumors. J Neurosurg 1991; 75: 941–6
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo C, O'Brien J P, Casals D, Bertino J R, Melamed M R. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 1990; 38: 1277–87
   PubMed Web of Science ®Google Scholar
• Schlaifer D, Laurent G, Chittal S, et al. Immuno-histochemical detection of multidrug resistance associated P-glycoprotein in tumour and stromal cells of human cancers. Br J Cancer 1990; 62: 177–82
   PubMed Web of Science ®Google Scholar
• Becker I, Becker K.-F., Meyerman R, Holt V. The multidrug resistance gene MDR 1 is expressed in human glial tumors. Acta Neuropathol (Barl) 1991; 82: 516–19
   PubMed Web of Science ®Google Scholar
• Hamada H, Tsuruo T. Functional role for the 170-to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc Nat Acad Sci USA 1986; 83: 7785–9
   PubMed Web of Science ®Google Scholar
• Grogan T, Dalton W, Rybski J, et al. Optimization of immunocytochemical P-glycoprotein assessment in multidrug-resistant plasma cell myeloma using three antibodies. Lab Invest 1990; 63: 815–24
   PubMed Web of Science ®Google Scholar
• Tishler D M, Weinberg K I, Sender L S, Nolta J A, Raffel C. Multidrug resistance gene expression in pediatric primitive neuroectodermal tumors of the central nervous system. Neurosurg 1992; 76: 507–12
   Web of Science ®Google Scholar
• Thiebaut F, Tsuruo T, Hamada H, Gottesman M M, Pastan I, Willingham M C. Immunohisto-chemical localization in normal tissues of different epitopes in the multidrug transport protein P170, Evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. J Histochem Cytochem 1989; 37: 159–64
   PubMed Web of Science ®Google Scholar
• Hegmann E J, Bauer H C, Kerbel R S. Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells. Cancer Res 1992; 52: 6969–75
   PubMed Web of Science ®Google Scholar
• Tatsuta T, Naito M, Oh-Hara T, Sugawara I, Tsuruo T. Functional involvement of P-glycoprotein in the blood-brain barrier. J Biol Chem 1992; 267: 20383–91
   PubMed Web of Science ®Google Scholar
• Sonneveld P, Dune B GM, Lockhorst H M, et al. Modulation of multidrug-resistant multiple myeloma by cyclosporin. Lancet 1992; 340: 255–9
   PubMed Web of Science ®Google Scholar
• Genekas A K, Bailey C C, Michaelis J, Wellek S, Kleihues P, Niethammer D. SIOP/GPO medulloblastoma Trial II-status report. Proc XXI SIOP Meeting, Prague 1989; 221: 335–6
   Google Scholar
• Vick N A, Khandekar J D, Bigner D D. Chemotherapy of brain tumors. The “blood-brain barrier” is not a factor. Arch Neurol 1977; 34: 523–6
   PubMed Web of Science ®Google Scholar
• Efferth T, Mattern J, Volm M. Immunohistochem-ical detection of P-glycoprotein, glutathione-S-transferase, and DNA topoisomerase II in human tumors. Oncology 1992; 49: 368–75
   PubMed Web of Science ®Google Scholar
• Bloom H JG, Bessell E M. Medulloblastoma in adults: a review of 47 patients treated between 1952 and 1981. Int J Radiat Oncol Biol Phys 1990; 18: 763–72
   PubMed Web of Science ®Google Scholar
• Jenkin D, Goddard K, Armstrong D, et al. Posterior fossa medulloblastoma in childhood: treatment results and a proposal for a new staging system. Int J Radiat Oncol Biol Phys 1990; 19: 265–74
   PubMed Web of Science ®Google Scholar
• Finlay J L, Goins S C. Brain Tumors in Children. III. Advances in Chemotherapy. Am J Pediat He-matol/Oncol 1987; 9: 264–71
   PubMed Web of Science ®Google Scholar
• Gilbertson R J, Jaros E B, Perry R H, Pearson A DJ. Prognostic factors in medulloblastoma (letter). Lancet 1992; 340: 480
   PubMed Web of Science ®Google Scholar